Ultragenyx Pharmaceutical (RARE) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 195.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.00 |
| Dec 31, 2025 | -562.00 |
| Sep 30, 2025 | -1,113.00 |
| Jun 30, 2025 | -814.00 |
| Mar 31, 2025 | -1,401.00 |
| Dec 31, 2024 | -1,668.00 |
| Sep 30, 2024 | -1,387.00 |
| Jun 30, 2024 | -2,260.00 |
| Mar 31, 2024 | -2,994.00 |
| Dec 31, 2023 | -2,756.00 |
| Mar 31, 2023 | -834.00 |
| Dec 31, 2022 | -223.00 |
| Sep 30, 2022 | 189.00 |
| Jun 30, 2022 | 153.00 |
| Mar 31, 2022 | 1,493.00 |
| Dec 31, 2021 | 2,676.00 |
| Sep 30, 2021 | 2,502.00 |
| Jun 30, 2021 | 2,637.00 |
| Mar 31, 2021 | 3,923.00 |
| Dec 31, 2020 | 5,901.00 |
| Mar 31, 2020 | 866.00 |
| Dec 31, 2019 | 613.00 |
| Sep 30, 2019 | 147.00 |
| Jun 30, 2019 | 98.00 |
| Mar 31, 2019 | -1,182.00 |
| Dec 31, 2018 | -2,891.00 |
| Sep 30, 2018 | -2,833.00 |
| Jun 30, 2018 | -2,402.00 |
| Mar 31, 2018 | -3,373.00 |
| Dec 31, 2017 | -5,436.00 |
| Sep 30, 2017 | -4,719.00 |
| Jun 30, 2017 | -3,602.00 |
| Mar 31, 2017 | -2,099.00 |